INSERM, UMR 791, LIOAD, Faculté de Chirurgie Dentaire, Université de Nantes, BP 84215, 44042, Nantes Cedex 1, France.
J Mater Sci Mater Med. 2011 Mar;22(3):593-600. doi: 10.1007/s10856-010-4219-x. Epub 2011 Jan 8.
Synthetic calcium phosphate ceramics as β-tricalcium phosphate (Ca(3)(PO(4))(2); β-TCP) are currently successfully used in human bone surgery. The aim of this work was to evaluate the influence of the presence of sodium ion in β-TCP on its mechanical and biological properties. Five Na-doped-β-TCP [Ca(10.5-x/2)Na(x)(PO(4))(7), 0 ≤ x ≤ 1] microporous pellets were prepared via solid phase synthesis, and their physico-chemical data (lattice compacity, density, porosity, compressive strength, infrared spectra) denote an increase of the mechanical properties and a decrease of the solubility when the sodium content is raised. On the other hand, the in vitro study of MC3T3-E1 cell activity (morphology, MTS assay and ALP activity) shows that the incorporation of sodium does not modify the bioactivity of the β-TCP. These results strongly suggest that Na-doped-β-TCP appear to be good candidates for their use as bone substitutes.
合成磷酸钙陶瓷作为β-磷酸三钙(Ca(3)(PO(4))(2);β-TCP)目前已成功应用于人体骨外科。本工作旨在研究钠离子对β-TCP 的机械和生物学性能的影响。采用固相合成法制备了五种 Na 掺杂β-TCP [Ca(10.5-x/2)Na(x)(PO(4))(7),0≤x≤1]多孔微球,其物理化学数据(晶格密度、密度、孔隙率、抗压强度、红外光谱)表明,随着钠含量的增加,机械性能提高,溶解度降低。另一方面,MC3T3-E1 细胞活性(形态、MTS 测定和 ALP 活性)的体外研究表明,钠的掺入并不改变β-TCP 的生物活性。这些结果强烈表明,Na 掺杂β-TCP 可作为骨替代物的候选材料。